Search Results (234)

Background/Objectives: Holy basil (Ocimum tenuiflorum L.) essential oil exhibits antioxidant, antimicrobial, and anesthetic activities, mainly due to eugenol, methyl eugenol, and β-caryophyllene. However, its clinical application is limited by poor water solubility, instability, and low bioavailability. This study developed and compared two delivery systems, self-nanoemulsifying drug delivery systems (SNEDDS) and microemulsions (ME), to enhance their stability and fish anesthetic efficacy. Methods: The optimized SNEDDS (25% basil oil, 8.33% coconut oil, 54.76% Tween 80, 11.91% PEG 400) and ME (12% basil oil, 32% Tween 80, 4% sorbitol, 12% ethanol, 40% water) were characterized for droplet size, PDI, zeta potential, pH, and viscosity. Stability was evaluated by monitoring droplet size and PDI over time and by determining the retention of eugenol, methyl eugenol, and β-caryophyllene after storage at 45 °C. Fish anesthetic efficacy was tested in koi carp (Cyprinus carpio var. koi). Results: SNEDDS maintained a small droplet size (~22.78 ± 1.99 nm) and low PDI (0.188 ± 0.088 at day 60), while ME showed significant size enlargement (up to 177.10 ± 47.50 nm) and high PDI (>0.5). After 90 days at 45 °C, SNEDDS retained 94.45% eugenol, 94.08% methyl eugenol, and 88.55% β-caryophyllene, while ME preserved 104.76%, 103.53%, and 94.47%, respectively. In vivo testing showed that SNEDDS achieved faster anesthesia (114.70 ± 24.80 s at 120 ppm) and shorter recovery (379.60 ± 15.61 s) than ME (134.90 ± 4.70 s; 473.80 ± 16.94 s). Ethanol failed to induce anesthesia at 40 ppm and performed poorly compared to SNEDDS and ME at other concentrations (p < 0.0001). Conclusions: SNEDDS demonstrated superior physical stability and fish anesthetic performance compared to ME. These findings support SNEDDS as a promising formulation for delivering holy basil essential oil in biomedical and aquaculture applications. Full article

Background: Salivary pH plays a critical role in oral health by influencing enamel demineralization, buffering capacity, and the ecology of oral microbiota. Essential oils such as Origanum vulgare (oregano) possess well-documented antimicrobial properties that may reduce acidogenic bacterial activity. However, the effects of edible delivery systems like jellies on salivary pH modulation and their potential interactions with hormonal states remain poorly understood. Methods: This study evaluated the in vitro antimicrobial activity of an oregano-oil-based jelly formulation against standard bacterial (Staphylococcus aureus, Streptococcus pyogenes, and Escherichia coli) and fungal (Candida albicans) strains using the Kirby–Bauer disc diffusion method. Additionally, a human trial (n = 91) measured salivary pH before and after administration of the oregano-oil jelly. Participants were characterized by age, smoking status, menopausal status, and presence of menstruation. Multiple linear regression was used to identify predictors of final salivary pH. Results: The oregano-oil jelly demonstrated strong in vitro antimicrobial activity, with inhibition zones up to 8 mm for E. coli and C. albicans. In vivo, mean unstimulated salivary pH increased from 6.94 to 7.07 overall, indicating a mild alkalinizing effect. However, menstruating participants showed a significant decrease in final pH (from 7.03 to 6.78). Multiple regression identified menstruation as a significant negative predictor (β = −0.377, p < 0.001) and initial pH as a positive predictor (β = +0.275, p = 0.002). Menopausal status was not a significant predictor, likely due to the small sample size. Conclusions: Oregano-oil jellies may represent a promising natural approach to support oral health by increasing salivary pH and providing strong antimicrobial activity. However, physiological states such as menstruation can significantly modulate this response, underscoring the importance of personalized or phase-aware oral care strategies. Further studies with larger, diverse cohorts and controlled hormonal assessments are needed to validate these findings and optimize product formulations. Full article

The conventional agricultural industry largely relies on pesticides to maintain healthy and viable crops. Application of fungicides, both pre- and post-harvest of crops, is the go-to method for avoiding and eliminating Botrytis cinerea, the fungal pathogen responsible for gray mold. However, conventional fungicides and their residues have purported negative environmental and health impacts. Natural products, such as essential oils, are viewed as a promising alternative to conventional fungicides. The current research is an in vitro study on the antifungal activity of a natural water-based fungicide (N.F.), which uses a blend of essential oils (ajowan, cassia, clove, eucalyptus, lemongrass, oregano) as the active ingredients against B. cinerea. Compared to conventional fungicides tested at the same concentration (50 μL/mL), those with active ingredients of myclobutanil or propiconazole; the N.F. demonstrated significant (F(3,16) = 54, p = <0.001) and complete fungal growth inhibition. While previous research has largely focused on the antifungal properties of single essential oils and/or isolated compounds from essential oils, this research focuses on the efficacy of using a blend of essential oils in a proprietary delivery system. This research is of importance to the fields of agronomy, ecology, and health sciences. Full article

This review examines the pharmaceutical applications of essential oils (EOs) and terpenes, highlighting their dual role as therapeutic agents and natural penetration enhancers. These volatile, hydrophobic compounds have well-documented antimicrobial, antioxidant, and anti-inflammatory properties. However, their clinical potential is limited by poor water solubility, high volatility, and sensitivity to environmental factors, including light, heat, and oxygen. To address these challenges, various advanced delivery systems have been developed to enhance stability, bioavailability, and controlled release. These systems not only protect chemical integrity but also exploit these compounds’ abilities to interact with lipid membranes, facilitating the transport of active compounds across biological barriers. Additionally, their inherent antimicrobial properties can contribute to the overall stability of formulations. The review critically examines the incorporation of terpenes and major essential oil (EO) components, such as limonene, linalool, eugenol, α-pinene, and menthol, into delivery systems, assessing their performance in enhancing drug permeability and targeting specific tissues. Current challenges and future directions in terpenes and EO-based delivery strategies are discussed, highlighting their promising role in developing multifunctional and efficient pharmaceutical formulations. Full article

Exercise-induced muscle damage (EIMD) initiates an inflammatory response that is essential for tissue repair. However, when prolonged or excessive, this response can impair recovery and muscular performance. Specialized pro-resolving mediators (SPMs), derived from the metabolism of omega-3 (n-3) polyunsaturated fatty acids (PUFAs), facilitate the resolution of inflammation without causing immunosuppression. Evidence from preclinical studies indicates that SPM administration accelerates muscle repair and functional recovery by enhancing the clearance of apoptotic cells, suppressing pro-inflammatory signaling and modulating macrophage polarization. However, translation to human applications remains limited as commercially available SPM-enriched marine oils do not contain active SPMs but rather their monohydroxylated precursors, including 14-Hydroxy-Docosahexaenoic Acid (14-HDHA), 17-Hydroxy-Docosahexaenoic Acid (17-HDHA), and 18-Hydroxy-Eicosapentaenoic Acid (18-HEPE) in addition to low doses of the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Furthermore, the variable increases in circulating SPM concentrations as a result of dietary intake of EPA and DHA, whether from fish or fish oil supplements, and the wide diversity of SPM molecules (many of which remain under investigation), highlight the complexity of their structural and functional networks. While advances in lipidomics have identified SPMs and their pathway intermediates in human biological samples, further research is needed to determine optimal dosing strategies, delivery mechanisms, and the real impact of SPM-enriched marine oil on athletic performance and recovery. This narrative review examines the biological rationale and current evidence surrounding SPM-enriched marine oil supplementation and its potential to enhance muscle recovery following EIMD. By synthesizing findings from preclinical and human studies, the potential of SPM-enriched supplementation as a novel tool for optimizing performance recovery in athletic populations is reviewed to inform future research directions. Full article

Biomimetic peptides represent a growing class of active ingredients in modern cosmeceuticals, designed to mimic the function of the naturally occurring peptides involved in skin homeostasis, repair, and regeneration. Among them, acetyl hexapeptide-8 (AH-8), often referred to as a “botox-like” peptide, has received considerable attention for its potential to dynamically reduce wrinkles through the modulation of neuromuscular activity. AH-8 is widely used in topical formulations intended for anti-aging effects, scar treatment, and skin rejuvenation. This review provides a comprehensive overview of the structure and proposed mechanisms of action of AH-8, with particular focus on its efficacy and skin penetration properties. Due to its hydrophilic nature and relatively large molecular size, AH-8 faces limited permeability through the lipophilic stratum corneum, making effective dermal delivery challenging. Formulation strategies such as oil-in-water (O/W) and multiple water-in-oil-in-water (W/O/W) emulsions have been explored to enhance its delivery, but the ability of AH-8 to reach neuromuscular junctions remains uncertain. Preclinical and clinical studies indicate that AH-8 may reduce wrinkle depth, improve skin elasticity, and enhance hydration. However, the precise biological mechanisms underlying these effects—particularly the peptide’s ability to inhibit muscle contraction when applied topically—remain incompletely understood. In some studies, AH-8 has also shown beneficial effects in scar remodeling and sebum regulation. Despite promising cosmetic outcomes, AH-8’s low skin penetration limits its bioavailability and therapeutic potential. This review emphasizes the need for further research on formulation science and delivery systems, which are essential for optimizing the effectiveness of peptide-based cosmeceuticals and validating their use as non-invasive alternatives to injectable treatments. Full article

The rising prevalence of bacterial antibiotic resistance remains a significant challenge, while many existing antibacterial agents exhibit limited efficacy and notable adverse effects. Edible plants offer a promising avenue for developing novel antimicrobial drugs and preservatives. Etrog citron (Citrus medica L.) and its bioactive phytochemicals have demonstrated activity against various pathogenic microorganisms. However, the potential application of these compounds is hindered by factors such as poor solubility, limited bioavailability, and unclear mechanisms of action. This review consolidates key findings on the antimicrobial properties of extracts and essential oils derived from different parts of Citrus medica, emphasizing strategies for improving the delivery of these bioactive compounds. Full article

Thymol, a monoterpenoid phenol present in the essential oils of several aromatic plants, has attracted considerable attention for its anti-inflammatory effects, often in combination with other bioactive compounds. This work explores the mechanisms behind the anti-inflammatory activity of thymol and thymol-rich essential oils, summarizing recent experimental findings. Inflammation, a key factor in numerous chronic diseases, can be modulated by targeting essential molecular pathways, such as MAPK, NF-κB, JAK/STAT, and arachidonic acid signaling. Thymol has been shown to influence these pathways, reducing the production of pro-inflammatory cytokines and mediators. Beyond its anti-inflammatory effects, thymol also exhibits a broad range of biological activities, including antimicrobial, antioxidant, and anticancer properties. The applications of thymol and thymol-containing essential oils in therapeutic formulations, food additives, and veterinary medicine are also reviewed. Despite promising preclinical results, challenges such as low bioavailability and toxicity at high doses limit their clinical use. Recent developments in drug delivery systems, such as encapsulation in micro- and nanoparticles, are suggested as strategies to enhance efficacy. Additionally, the synergistic effects of thymol with other natural products are examined, offering the potential for improved therapeutic outcomes. Full article

Background: Tuberculosis remains a significant global health issue, and the rise of drug-resistant strains is becoming increasingly concerning. Currently, treatment options are limited to systemic regimens; however, developing topical drug delivery systems could offer advantages for treating cutaneous tuberculosis (CTB) when applied directly to the lesions. We developed topical emulsions using the self-emulsification mechanism that combine fixed doses of isoniazid (INH) and rifampicin (RIF) using a quality-by-design approach. Methods: Preformulation studies pertaining to drug solubility in various solvents, the construction of pseudoternary diagrams to identify self-emulsification regions for each tested excipient combination, and the preparation of checkpoint formulations were conducted and visually examined. Formulations displaying no physical instabilities were subsequently exposed to characterization experiments, including droplet size determination, zeta potential, size distribution, viscosity, pH, self-emulsification, cloud point, robustness to dilution, and thermodynamic stability assessment. Three selected formulations were consequently subjected to membrane release experiments, followed by skin diffusion studies, and INH and RIF stability in these emulsions was determined, because these drugs have a known interaction. Conclusions: While incorporating essential oils in a topical formulation improved RIF solubility, it also resulted in several instabilities. RIF exhibited greater susceptibility to degradation under higher temperatures and lower pH conditions. However, drug release from all formulations tested was confirmed. Notably, olive oil microemulsions demonstrated the most favorable characteristics for dermal drug delivery; nonetheless, drug diffusion into and through the skin (which was not desired) could not be quantified. Despite these challenges, the findings indicate that topical drug delivery systems using the self-emulsification process can facilitate the direct treatment of CTB. Full article

A nanoliposome-integrated polymeric hydrogel was developed for the controlled release of essential oils (Argania spinosa, Passiflora edulis). A deep eutectic solvent (DES) composed of betaine and phytic acid enhanced the solubility and stability of essential oils, facilitating uniform encapsulation within nanoliposomes. The hydrogel exhibited a swelling capacity of 100% and retained 51.7% of water after 7 h, ensuring prolonged hydration. Structural analysis confirmed a homogeneous dispersion of nanoliposomes, contributing to the gradual release of bioactive components. Additionally, the hydrogel demonstrated high mechanical strength (7.5 MPa), ensuring flexibility and durability. The polymeric network, formed by acrylamide, sodium alginate, and bentonite, provided a stable and elastic matrix, optimizing water retention and mechanical performance. The controlled diffusion mechanism of the nanoliposomes was validated through in vitro release studies, indicating Fickian-controlled release behavior. These findings highlight the potential of this polymeric hydrogel system as a functional material for skincare formulations, offering enhanced hydration and sustained bioactive delivery. Full article

Bacterial antimicrobial resistance (AMR) represents a critical public health threat, with increasing resistance compromising the effectiveness of treatments worldwide. Resistance trends, such as fluctuating benzylpenicillin resistance in Staphylococcus aureus, highlight the growing urgency, with projections indicating a rise in resistance to various antibiotics, including complete resistance to gentamicin and tetracycline by 2027. Despite substantial efforts to develop new antibiotics and drug delivery systems, these approaches must undergo rigorous clinical evaluation to ensure their safety and efficacy. In parallel, alternative therapies, such as phytotherapy and apitherapy, have garnered attention for their potential in combating infections. Natural substances like tea tree essential oils and propolis, which exhibit antimicrobial properties, are being increasingly incorporated into novel drug delivery systems. However, much of the research on these materials is not new, with several studies already exploring their effectiveness. To address the escalating AMR crisis, combining advanced therapies with alternative medicine could offer a promising solution. Advanced therapy products could target bacterial genomes and enhance the effectiveness of antibiotics and natural substances. This integrated approach remains underexplored in pre-clinical and clinical trials, presenting future research opportunities to develop more effective strategies in combating AMR. Given the rapid spread of resistant infections, there is an urgent need for innovative antimicrobial agents to overcome emerging resistance mechanisms and improve diagnoses and treatments. Full article

Metal Organic Frameworks (MOFs) are a unique family of tailor-made porous materials that have gained significant attention for their properties and their applications in various fields, including agriculture and agrifood. The aim of this review is to explore the potential of MOFs as smart carriers and delivery mediums of essential oils (EOs) and/or aromatic volatiles. Emphasis is given to their potential to be applied in crop protection and fresh food preservation. MOFs indeed present highly promising physicochemical characteristics in order to be applied in such sectors. To name a few, their high surface area, tunable porosity, and customizable functionalities, make them ideal carriers for EOs, which are established for their antimicrobial properties but their wider practical applications are limited by their volatility and chemical sensitivity. The encapsulation of EOs in MOFs enhances their stability, controlled release, and bioavailability, providing effective solutions for sustainable agriculture and food safety. Furthermore, in this review we discuss various MOF types, emphasizing the most recent literature references, including cyclodextrin-based MOFs, Cu²⁺ based MOFs, Zn²⁺ based MOFs as well as Zr⁴⁺ MOFs. In this work, we attempt to highlight the interactions and physicochemical characteristics (e.g., pore size and pore functionality), that contribute to the encapsulation of different EOs within MOFs. We focus on a detailed discussion of the external stimuli that can trigger the targeted release of EOs, such as pH changes caused by pathogenic microbial activity. Additionally, we examine the potential benefits of the EOs encapsulation in MOFs, including the reduction of premature evaporation due to their volatile nature and their improved delivery to targeted sites. These aspects are explored within the frameworks’ food safety enhancement, extended shelf life and the promotion of sustainable food preservation alternatives. Furthermore, we address MOFs’ limitations such as biocompatibility, scalability and chemical stability under field conditions to further comprehend their potential as EO carriers in agrifood applications, emphasizing food preservation and protection. Finally, this work aims to contribute to global challenges in nutrition and sustainable agriculture. Full article

Biofilms, structured microbial consortia embedded in self-produced extracellular matrices, pose significant challenges across the medical, industrial, and environmental sectors due to their resistance to antimicrobial therapies and ability to evade the immune system. Their resilience is driven by multifaceted mechanisms, including matrix-mediated drug sequestration, metabolic dormancy, and quorum sensing (QS)-regulated virulence, which collectively sustain persistent infections and contribute to the amplification of antimicrobial resistance (AMR). This review critically examines the potential of plant-derived essential oils (EOs) as innovative agents for biofilm control. EOs exhibit broad-spectrum antibiofilm activity through multi-target mechanisms, including disrupting initial microbial adhesion, degrading extracellular polymeric substances (EPSs), suppressing QS pathways, and compromising membrane integrity. Their ability to act synergistically with conventional antimicrobials at sub-inhibitory concentrations enhances therapeutic efficacy while reducing the selection pressure for resistance. Despite their potential, EO applications face technical challenges, such as compositional variability due to botanical sources, formulation stability issues, and difficulties in standardization for large-scale production. Clinical translation is further complicated by biofilm stage- and strain-dependent efficacy, insufficient in vivo validation of therapeutic outcomes, and potential cytotoxicity at higher doses. These limitations underscore the need for optimized delivery systems, such as nanoencapsulation, to enhance bioavailability and mitigate adverse effects. Future strategies should include combinatorial approaches with antibiotics or EPS-degrading enzymes, advanced formulation technologies, and standardized protocols to bridge laboratory findings to clinical practice. By addressing these challenges, EOs hold transformative potential to mitigate biofilm-associated AMR, offering sustainable, multi-target alternatives for infection management and biofilm prevention in diverse contexts. Full article

Long-acting injectable (LAI) formulations have revolutionized veterinary pharmaceuticals by improving patient compliance, minimizing dosage frequency, and improving therapeutic efficacy. These formulations utilize advanced drug delivery technologies, including microspheres, liposomes, oil solutions/suspensions, in situ-forming gels, and implants to achieve extended drug release. Biodegradable polymers such as poly(lactic-co-glycolic acid) (PLGA), and polycaprolactone (PCL) have been approved by the USFDA and are widely employed in the development of various LAIs, offering controlled drug release and minimizing the side effects. Various classes of veterinary medicines, including non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, and reproductive hormones, have been successfully formulated as LAIs. Some remarkable LAI products, such as ProHeart^® (moxidectin), Excede^® (ceftiofur), and POSILACTM (recombinant bovine somatotropin), show clinical relevance and commercial success. This review provides comprehensive information on the formulation strategies currently being used and the emerging technologies in LAIs for veterinary purposes. Additionally, challenges in characterization, in vitro testing, in vitro in vivo correlation (IVIVC), and safety concerns regarding biocompatibility are discussed, along with the prospects for next-generation LAIs. Continued advancement in the field of LAI in veterinary medicine is essential for improving animal health. Full article

The emergence of antimicrobial resistance among foodborne pathogens has intensified the search for alternative biocontrol strategies. Among these, essential oils (EOs) and bacteriophages have gained increasing attention, due to their natural origin and antimicrobial potential. This narrative review investigates their individual and combined use as innovative tools for improving food safety. We discuss the mechanisms of action, current food applications, and regulatory or technical limitations associated with both EOs and phages. Particular emphasis is placed on their complementary characteristics, which may enhance efficacy when used together. An in-depth analysis of five key studies investigating synergistic EO–phage combinations against Staphylococcus aureus, Escherichia coli, and Salmonella Typhimurium is presented. These studies, conducted in both in vitro and food-based systems, reveal that antimicrobial synergy is often dose- and temperature-dependent. Optimized combinations lead to enhanced bacterial reduction and reduced resistance development. However, several challenges remain, including sensory alterations in food products, phage inactivation by EO compounds, and host cell destruction at high EO doses. The review concludes that while EOs and phages face limitations when applied independently, their strategic combination shows substantial promise. Future research should focus on formulation development, delivery systems, and regulatory alignment to unlock their full synergistic potential. Full article